Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

Share Price is delayed by 15 minutes
Get Live Data
811.20    0.00 (0.00%)
Bid:
790.00
Ask:
900.00
Spread: 110.00 (13.924%)
Market Cap: £10.20b
INF Live PriceLast checked at - London Stock Exchange

Intraday Informa Share Chart

Transaction in Own Shares

13 Nov 2023 07:00

RNS Number : 1522T
Informa PLC
13 November 2023
 

Informa PLC Press Release

13 November 2023

Informa Share Buyback Programme

Update on GAP 2 shareholder returns

Informa (LSE: INF.L), the international Academic Markets, B2B Markets and Digital Services Group today provided an update on its Share Buyback Programme that forms part of the 2021-2024 Growth Acceleration Plan 2 ('GAP 2').

Share Buyback Programme

GAP 2 is Informa's four-year programme to create a more focused, higher growth business. This includes accelerated investment in its two businesses with scale leadership positions, B2B Markets and Academic Markets, and the divestment of its Informa Intelligence portfolio of businesses.

GAP 2 also includes a commitment to accelerate shareholder returns, sharing some of the divestment proceeds with shareholders, alongside increased investment into the Group's two leadership businesses. This led to the resumption of ordinary dividends and a £1bn Share Buyback Programme.

As part of this Share Buyback, on 10 November 2023, the Company purchased 469,115 ordinary shares for cancellation through Morgan Stanley & Co. International plc at an average price of 716.50 pence per share. The highest and lowest purchase price paid per share were 723.40 and 712.80 respectively, with the aggregate details of shares purchased by trading venue as outlined in the table below:

Trading venue

Weighted average price paid per share (GBp)

Aggregate number of shares purchased

Lowest price paid per share(GBp)

Highest price paid per share(GBp)

London Stock Exchange

716.48

190,616

713.20

723.40

Chi-X (CXE)

716.57

220,149

712.80

723.40

BATS (BXE)

716.38

56,410

713.20

723.40

AQUIS (AQXE)

715.86

1,940

714.40

717.80

Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue, and its total voting rights, will be 1,376,074,732 ordinary shares. The Company does not hold any shares in Treasury.

In accordance with Article 5(1)(b) of the Market Abuse Regulation, a full breakdown of the individual trades made as part of the buyback programme is detailed in the attachment.

http://www.rns-pdf.londonstockexchange.com/rns/1522T_1-2023-11-10.pdf

Enquiries

Richard Menzies-Gow, Director of IR & Communications

+44 (0) 20 8052 2787

Heledd Hanscomb, Deputy Company Secretary

+44 (0) 20 8052 0661

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBIBDBBXBDGXG
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 202612:14 pmRNSHolding(s) in Company
1st Jun 202610:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20262:52 pmRNSHolding(s) in Company
22nd May 20269:40 amRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 202610:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSAnnual Financial Report and Notice of 2026 AGM
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSAppointment of inD CEO
15th Apr 20263:30 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 202612:01 pmRNSHolding(s) in Company
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSFinal Results
9th Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:11 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 202612:32 pmRNSDirectorate change
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202610:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.